Free Trial

Schrödinger (SDGR) Projected to Post Quarterly Earnings on Wednesday

Schrödinger logo with Medical background

Schrödinger (NASDAQ:SDGR - Get Free Report) is projected to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $83.20 million for the quarter. Individual interested in registering for the company's earnings conference call can do so using this link.

Schrödinger Trading Down 5.7 %

SDGR stock traded down $1.36 on Friday, hitting $22.64. The company's stock had a trading volume of 1,246,251 shares, compared to its average volume of 998,259. The firm has a 50 day moving average of $22.16 and a two-hundred day moving average of $20.47. Schrödinger has a 1 year low of $16.67 and a 1 year high of $33.63. The stock has a market cap of $1.65 billion, a price-to-earnings ratio of -9.68 and a beta of 1.61.

Wall Street Analyst Weigh In

SDGR has been the subject of several recent analyst reports. KeyCorp raised their price target on Schrödinger from $25.00 to $27.00 and gave the company an "overweight" rating in a report on Friday, January 24th. BMO Capital Markets upped their price target on Schrödinger from $25.00 to $28.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $32.11.

Read Our Latest Research Report on SDGR

Schrödinger Company Profile

(Get Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

See Also

Earnings History for Schrödinger (NASDAQ:SDGR)

Should You Invest $1,000 in Schrödinger Right Now?

Before you consider Schrödinger, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.

While Schrödinger currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines